Product Information
BETAMETHASONE VALER 0.1% OINTM is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.6144 per GM under NDC 00168003315. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
NDC
00168003315
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE VALERATEApproval Type
New Drug (NDA)
FDA Application
NDA018865FDA Approved
8/31/1983
TE Code
AB
On Market Since
8/31/1983
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE VALER 0.1% OINTM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6144 per GM |
|---|---|
| All-time high | $1.0338 (May 13, 2015) |
| All-time low | $0.5556 (Jul 17, 2024) |
| 52-week high | $0.6534 |
| 52-week low | $0.5977 |
| Median price | $0.8034 |
| Average price | $0.7919 |
| Largest weekly change | +30.6% (Apr 21, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the betamethasone valerate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
betamethasone valerate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE VALER 0.1% OINTM?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE VALER 0.1% OINTM, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.6144 per GM (NDC 00168003315), effective Sep 30, 2026.
How has the price of BETAMETHASONE VALER 0.1% OINTM changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE VALER 0.1% OINTM has declined 35.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE VALER 0.1% OINTM?
Since Nov 28, 2013, the NADAC for BETAMETHASONE VALER 0.1% OINTM has ranged from a low of $0.5556 (Jul 17, 2024) to a high of $1.0338 (May 13, 2015), with a median of $0.8034 per GM.
Are there cheaper alternatives to BETAMETHASONE VALER 0.1% OINTM?
No other NADAC-published product currently shares the active ingredient and strength of BETAMETHASONE VALER 0.1% OINTM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BETAMETHASONE VALER 0.1% OINTM?
BETAMETHASONE VALER 0.1% OINTM (NDC 00168003315) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.